Kurser indlæses...
Prognose
Analytikernes gennemsnitlige kursmål er 27,63 € (+141,52 %). Medianen er 27,63 € (+141,52 %).
| Køb |
2 |
| Behold |
2 |
| Sælg |
0 |
Nyheder Til nyhedsfeedet
Nature's Sunshine targets $1 billion in sales after record Q2, cuts full-year guidance
Nature's Sunshine reported a record second quarter with $117 million in net sales and a 73.7% gross margin, but management lowered full-year net sales guidance to $490–500 million and trimmed EBITDA guidance amid currency headwinds and a 20% sales decline in China. North America digital sales rose 26% and social commerce jumped 177%, with autoship subscriptions gaining share, while SG&A and volume incentives increased as growth investments ramp. The company named Ruth Perkins CFO and Janine Weber president of North America to support a push to double sales, but risks remain from the China setback and a pressured North American direct-selling channel. » Mere på finance.yahoo.com
Nature’s Sunshine will double revenue to $1bn and increase EBITDA margin to 15%
Nature’s Sunshine presented at the growth conference a plan to accelerate growth through geographic expansion, digital D2C growth, targeted bolt‑on acquisitions and product innovations. The goal is to raise revenue from about $480m (2025) to $1bn and lift the EBITDA margin from 10% to 15%; the company has roughly $100m in cash and no debt. Key drivers are the fast‑growing digital business, the Asia‑Pacific region (40% of revenue) and an in‑house manufacturing capacity in Utah intended to enable economies of scale. Management emphasizes a disciplined M&A approach (target sizes $75–125m) and a multi‑channel strategy with separate product lines for advisors and digital channels. » Mere på de.investing.com
Nature’s Sunshine misses Q2 earnings and revenue forecasts, stock falls after hours
Nature’s Sunshine reported adjusted EPS of $0.21 for Q2 2026 on revenue of $117.0 million, both below consensus estimates ($0.29 and $123.7 million). Despite record sales for a second quarter and a gross margin of 73.7%, management cut the full-year outlook due to weaker sales in China and currency headwinds. The digital business grew strongly, with social commerce up 177%, while the North American direct selling business softened. The stock fell about 9.9% in after-hours trading; the company holds $82.5 million in cash and has no debt. » Mere på de.investing.com
Historisk udbytte Udbytte
Alle nøgletal for udbytte Alle nøgletalVirksomhedstal
| (EUR) | juni 2026 | YoY |
|---|---|---|
| Omsætning | 102,5 mio. | 5,29 % |
| Bruttofortjeneste | 75,51 mio. | 8,14 % |
| Nettoresultat | 3,1 mio. | 31,49 % |
| EBITDA | 7,64 mio. | 18,64 % |
Fundamentale data
| Nøgletal | Værdi |
|---|---|
Markedsværdi | 202,79 mio. € |
Antal aktier | 17,6 mio. |
Højeste/laveste i 52 uger | 25,08 € - 10,62 € |
| Udbytte | Nej |
Beta | 0,81 |
P/E (PE Ratio) | 12,68 |
PEG (PEG Ratio) | 0,37 |
K/I (PB Ratio) | 1,36 |
P/S (PS Ratio) | 0,46 |
Virksomhedsprofil
Nature's Sunshine Products, Inc., et naturlige sundheds- og wellnessselskab, fremstiller og sælger primært kosttilskud og plejeprodukter i Asien, Europa, Nordamerika, Latinamerika og internationalt. Selskabet tilbyder generelle sundhedsprodukter relateret til støtte for blodsukker, knoglesundhed, cellesundhed, kognitiv funktion, ledsundhed, humør, seksuel sundhed, søvn, sport og energi samt syn. Selskabet leverer også produkter til immunforsvar, kredsløb og fordøjelse; og plejeprodukter, såsom olier og lotioner, aloe vera-geler, urtebaserede shampooer, urtebaseret hudbehandling, tandpasta og hudrensere, samt produkter til vægtkontrol. Det tilbyder sine produkter under mærkerne Nature's Sunshine og Synergy WorldWide gennem en salgsstyrke bestående af uafhængige konsulenter. Selskabet blev grundlagt i 1972 og har hovedkontor i Lehi, Utah.
| Navn | NATURE'S SUNSHINE PRODS |
| CEO | Kenneth G. Romanzi |
| Hjemsted | Lehi,
ut USA |
| Websted | |
| Sektor | Materialer |
| Branche | Kemikalier |
| Børsnotering | 25.06.2009 |
| Medarbejdere | 806 |
Tickersymboler
| Børs | Symbol |
|---|---|
NASDAQ | NATR |